BlackRock’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24M Buy
4,920,083
+2,769,210
+129% +$13.5M ﹤0.01% 2864
2025
Q1
$7.96M Buy
2,150,873
+290,269
+16% +$1.07M ﹤0.01% 3395
2024
Q4
$7.44M Buy
1,860,604
+258,414
+16% +$1.03M ﹤0.01% 3516
2024
Q3
$11.2M Buy
1,602,190
+118,928
+8% +$829K ﹤0.01% 3301
2024
Q2
$8.41M Buy
1,483,262
+1,176,196
+383% +$6.67M ﹤0.01% 3424
2024
Q1
$4.09M Buy
307,066
+192,968
+169% +$2.57M ﹤0.01% 3701
2023
Q4
$701K Sell
114,098
-17,185
-13% -$106K ﹤0.01% 4271
2023
Q3
$331K Sell
131,283
-6,761
-5% -$17K ﹤0.01% 4470
2023
Q2
$723K Sell
138,044
-717
-0.5% -$3.76K ﹤0.01% 4295
2023
Q1
$658K Sell
138,761
-5,303
-4% -$25.1K ﹤0.01% 4383
2022
Q4
$775K Sell
144,064
-45,129
-24% -$243K ﹤0.01% 4412
2022
Q3
$1.33M Sell
189,193
-2,049
-1% -$14.4K ﹤0.01% 4292
2022
Q2
$1.77M Sell
191,242
-196,909
-51% -$1.82M ﹤0.01% 4216
2022
Q1
$6.99M Sell
388,151
-28,730
-7% -$517K ﹤0.01% 3700
2021
Q4
$10.9M Buy
416,881
+116,101
+39% +$3.05M ﹤0.01% 3561
2021
Q3
$10.8M Buy
300,780
+29,531
+11% +$1.06M ﹤0.01% 3581
2021
Q2
$14.9M Buy
271,249
+106,230
+64% +$5.83M ﹤0.01% 3411
2021
Q1
$13.7M Buy
165,019
+31,864
+24% +$2.64M ﹤0.01% 3338
2020
Q4
$15.1M Sell
133,155
-15,776
-11% -$1.79M ﹤0.01% 3088
2020
Q3
$4.53M Sell
148,931
-5,056
-3% -$154K ﹤0.01% 3524
2020
Q2
$6.77M Buy
153,987
+26,154
+20% +$1.15M ﹤0.01% 3336
2020
Q1
$4.58M Sell
127,833
-208
-0.2% -$7.46K ﹤0.01% 3333
2019
Q4
$8.55M Buy
128,041
+15,276
+14% +$1.02M ﹤0.01% 3275
2019
Q3
$17.5M Buy
112,765
+24,175
+27% +$3.75M ﹤0.01% 2865
2019
Q2
$7.64M Buy
88,590
+8,701
+11% +$750K ﹤0.01% 3331
2019
Q1
$11M Sell
79,889
-1,072
-1% -$148K ﹤0.01% 3049
2018
Q4
$32.5M Buy
80,961
+29,078
+56% +$11.7M ﹤0.01% 2457
2018
Q3
$36.7M Buy
51,883
+12,154
+31% +$8.6M ﹤0.01% 2530
2018
Q2
$21.2M Sell
39,729
-2,895
-7% -$1.55M ﹤0.01% 2799
2018
Q1
$4.79M Buy
+42,624
New +$4.79M ﹤0.01% 3401